Litcius/Paper detail

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

Bastian Neesgaard, Lauren Greenberg, José M. Miró, Katharina Grabmeier‐Pfistershammer, Gilles Wandeler, Colette Smith, Stéphane De Wit, Ferdinand Wit, Annegret Pelchen–Matthews, Cristina Mussini, Antonella Castagna, Christian Pradier, Antonella d’Arminio Monforte, Jörg Janne Vehreschild, Anders Sönnerborg, Alain Volny Anne, Andrew Carr, Loveleen Bansi‐Matharu, Jens Lundgren, H Garges, Felipe Rogatto, Robert Zangerle, Huldrych F. Günthard, Line Dahlerup Rasmussen, Coca Necsoi, Marc van der Valk, Marianna Menozzi, Camilla Muccini, Lars Peters, Amanda Mocroft, Lene Ryom

2022The Lancet HIV136 citationsDOIOpen Access PDF

Topics & Concepts

MedicineIntegrase inhibitorIntegraseProspective cohort studyHuman immunodeficiency virus (HIV)Cohort studyCohortDolutegravirAntiretroviral therapyGerontologyInternal medicineVirologyViral loadHIV-related health complications and treatmentsHIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium | Litcius